Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

COLLEGIUM PHARMACEUTICAL, INC Director's Dealing 2015

May 6, 2015

32163_dirs_2015-05-06_389b5f39-54ed-4c49-b4b1-3efd08fbdc08.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2015-05-06

Reporting Person: Fleming Alison B (Vice President, Product Devlp)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to purchase) $3.38 2015-11-01 Common Stock (1086) Direct
Stock Option (right to purchase) $3.38 2016-12-01 Common Stock (1086) Direct
Stock Option (right to purchase) $3.38 2017-11-01 Common Stock (1811) Direct
Stock Option (right to purchase) $.90 2019-04-23 Common Stock (1811) Direct
Stock Option (right to purchase) $.90 2020-02-26 Common Stock (1811) Direct
Stock Option (right to purchase) $3.31 2021-02-08 Common Stock (1449) Direct
Stock Option (right to purchase) $.48 2022-05-10 Common Stock (7246) Direct
Stock Option (right to purchase) $.48 2023-01-30 Common Stock (12681) Direct
Stock Option (right to purchase) $.28 2024-03-05 Common Stock (15623) Direct
Stock Option (right to purchase) $.28 2024-03-05 Common Stock (14492) Direct
Stock Option (right to purchase) $5.73 2025-03-19 Common Stock (60379) Direct

Footnotes

F1: All 1,086 options are exercisable.

F2: All 1,086 options are exercisable.

F3: All 1,811 options are exercisable.

F4: All 1,811 options are exercisable.

F5: All 1,811 options are exercisable.

F6: All 1,449 options are exercisable.

F7: 5,585 options are exercisable. The options vest and become exercisable over a 4-year period commencing on April 1, 2012. Twenty-five percent (25%) of the options vested and became exercisable on April 1, 2013 and then in equal monthly installments (rounded up to the nearest whole option) at the end of each monthly period over the remaining three years of the 4-year period.

F8: 7,397 options are exercisable. The options vest and become exercisable in equal installments (rounded up to the nearest whole option) at the end of each month over a 4-year period commencing on January 24, 2013.

F9: 4,557 options are exercisable. The options vest and become exercisable in equal installments (rounded up to the nearest whole option) on a monthly basis over a 4-year period commencing on March 5, 2014.

F10: 4,227 options are exercisable. The options vest and become exercisable over a 4-year period commencing on March 5, 2014. Twenty-five percent (25%) of the options vested and became exercisable on March 5, 2015 and then in equal monthly installments (rounded up to the nearest whole option) at the end of each monthly period over the remaining three years of the 4-year period.

F11: 1,258 options are exercisable. The options vest and become exercisable in equal installments (rounded up to the nearest whole option) on a monthly basis over a 4-year period commencing on March 19, 2015.